sábado, 1 de septiembre de 2018

Genomic Medicine XI: Research Directions in Genomic Medicine Implementation - National Human Genome Research Institute (NHGRI)

Genomic Medicine XI: Research Directions in Genomic Medicine Implementation - National Human Genome Research Institute (NHGRI)

couple talking to a doctor and DNA



New Directions in Genomic Medicine Implementation
This week, we highlight new information about implementation of genomic medicine and the role of public health resources and programs. Check out the NIH Genomic Medicine XI Conference: Research Directions in Genomic Medicine Implementation.
For information on the role of public health in implementation of genomic medicine, check out our resources and the tier 1 genomics tool kit.


Genomic Medicine XIResearch Directions in Genomic Medicine Implementation

September 5-6, 2018
Hilton La Jolla Torrey Pines Hotel
La Jolla, California
Genomic Medicine XI
On September 5-6, 2018, the National Human Genome Research Institute (NHGRI) will sponsor its 11th Genomic Medicine meeting - Genomic Medicine XI: Research Directions in Genomic Medicine Implementation - at the Hilton La Jolla Torrey Pines hotel in La Jolla, California. 
The objectives of the meeting will be to:
  • Summarize the current status of genomic medicine implementation research.
  • Identify obstacles to genomic medicine implementation and how to overcome them.
  • Define where clinical implementation of genomic medicine could or should be 5-10 years from now and how to get there.
  • Inform NHGRI strategic planning process regarding genomic medicine.
We invite you to attend and contribute to this meeting.  It will be webcast live on GenomeTV Live or you can register at to attend at your own cost.
The GM XI meeting has been planned in conjunction with the AGBT-Precision Health 2018 meeting which will follow immediately on the adjournment of our meeting at the same location. If your schedule permits you might find that meeting of considerable interest as well.

Wednesday, September 5

No hay comentarios: